{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:21:47Z","timestamp":1791134507325,"version":"4.1.0"},"reference-count":17,"publisher":"BMJ","issue":"6476","license":[{"start":{"date-parts":[[1985,4,20]],"date-time":"1985-04-20T00:00:00Z","timestamp":482803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1985,4,20]]},"abstract":"<jats:p>Twenty patients with the narcoleptic syndrome were treated separately with dexamphetamine sulphate tablets 10 and 30 mg, Dexedrine Spansules 10 mg, mazindol 4 mg, and fencamfamin hydrochloride 60 mg daily. Each drug was given for four weeks and the effects compared. In these dosages the reported frequency of attacks of narcolepsy was roughly halved with each treatment, dexamphetamine 30 mg daily being only slightly more potent than 10 mg. The subjective effects of Dexedrine tablets and Spansules could not be distinguished by most patients. Effects on mood, alertness, and sympathomimetic side effects were largely inseparable with all these drugs, but a decrease in appetite was not reported by patients with narcolepsy.<\/jats:p>","DOI":"10.1136\/bmj.290.6476.1167","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"1167-1170","source":"Crossref","is-referenced-by-count":48,"title":["Amphetamine, mazindol, and fencamfamin in narcolepsy."],"prefix":"10.1136","volume":"290","author":[{"given":"J","family":"Shindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Brincat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1985,4,20]]},"reference":[{"key":"ref_1","first-page":"148","article-title":"ect","volume":"1","author":"Dement, W.; Zarcone, V.; Varner, V.","year":"1972","unstructured":"Dement W, Zarcone V, Varner V, ect at. The prevalence of narcolepsy. Sleep Research 1972;1:148.","journal-title":"at. The prevalence of narcolepsy. Sleep Research"},{"key":"ref_2","first-page":"183","article-title":"Subjective effects of two anorexigenic agents-fenfluramine and AN448 in normal subjects","volume":"51","author":"Holmstrand, J.; Jonsson, J.","year":"1975","unstructured":"Holmstrand J, Jonsson J. Subjective effects of two anorexigenic agents-fenfluramine and AN448 in normal subjects. Postgrad MedJ 1975;51:183-6.","journal-title":"Postgrad MedJ"},{"issue":"27","key":"ref_3","first-page":"278","article-title":"Symptomatische Behandlung der pathologischen Schlafsucht, besonders der Narkolepsie","volume":"1931","author":"0, Janota","unstructured":"Janota 0. Symptomatische Behandlung der pathologischen Schlafsucht, besonders der Narkolepsie. Medizinische Klinik 1931;27:278-81.","journal-title":"Medizinische Klinik"},{"issue":"105","key":"ref_4","first-page":"2051","article-title":"The use of Benzedrine for the treatment of narcolepsy","volume":"1935","author":"Prinzmetal, M.; Bloomberg, W.","unstructured":"Prinzmetal M, Bloomberg W. The use of Benzedrine for the treatment of narcolepsy. JAMA 1935;105:2051-4.","journal-title":"JAMA"},{"key":"ref_5","series-title":"Proceedings of the Staff Meeting of the Mayo Clinic","first-page":"620","article-title":"The treatment of narcolepsy with methyl phenylpiperidylacetate; a preliminary report","volume":"31","author":"Daly, D.D.; Yoss, R.E.","year":"1956","unstructured":"Daly DD, Yoss RE. The treatment of narcolepsy with methyl phenylpiperidylacetate; a preliminary report. Proceedings of the Staff Meeting of the Mayo Clinic 1956;31:620-5."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1979.tb02976.x","article-title":"Mazindol in the treatment of narcolepsy","volume":"60","author":"Parkes, J.D.; Schachter, M.","year":"1979","unstructured":"Parkes JD, Schachter M. Mazindol in the treatment of narcolepsy. Acta Neurol Scand 1979;60:250-4.","journal-title":"Acta Neurol Scand"},{"key":"ref_7","first-page":"139","article-title":"AN448 on critical flicker fusion and heart rate in man","volume":"46","author":"Hedges, A.","year":"1972","unstructured":"Hedges A. AN448 on critical flicker fusion and heart rate in man. S Afr Med X 1972;46:139.","journal-title":"S Afr Med X"},{"key":"ref_8","first-page":"5","article-title":"Effects of drugs on the performance of a task by fatigued subjects","volume":"3","author":"Holliday, A.R.; Devery, W.J.","year":"1962","unstructured":"Holliday AR, Devery WJ. Effects of drugs on the performance of a task by fatigued subjects. Clin: Phar,nacol Ther 1962;3:5-15."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2125.1975.tb00466.x","article-title":"A single dose studv of trazodone with an assessment of its effect on mood and arousal","volume":"2","author":"Munday, B.; Kendall, M.J.; Mitchard, M.; Betts, T.A.","year":"1975","unstructured":"Munday B, Kendall MJ, Mitchard M, Betts TA. A single dose studv of trazodone with an assessment of its effect on mood and arousal. BrJ Clitn Pharmacol 1975; 2:19-24.","journal-title":"BrJ Clitn Pharmacol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp.43.2.171","article-title":"Fluroxamine and clomipramine in the treatment of cataplexy","volume":"43","author":"Schachter, M.; Parkes, J.D.","year":"1980","unstructured":"Schachter M, Parkes JD. Fluroxamine and clomipramine in the treatment of cataplexy. Y Neurol Neurosurg Psychiatry 1980;43:171-4.","journal-title":"Y Neurol Neurosurg Psychiatry"},{"key":"ref_11","article-title":"Influence of urinary pH on excretion of amphetamine","volume":"303","author":"Beckett, A.H.; Rowland, M.; Turner, P.","year":"1965","unstructured":"Beckett AH, Rowland M, Turner P. Influence of urinary pH on excretion of amphetamine. Lancet 1965;i:303.","journal-title":"Lancet"},{"key":"ref_12","first-page":"285","article-title":"Pharmacological analysis of a new anorectic substance: 5-hydroxy-5-(4'chlorophenyl)-2, 3-dihydro-5Himidazo-(2,1-a) isonidole (mazindol)","volume":"214","author":"Gogerty, J.H.; Penberthy, C.; Iorio, I.C.; Trapold, J.H.","year":"1975","unstructured":"Gogerty JH, Penberthy C, Iorio IC, Trapold JH. Pharmacological analysis of a new anorectic substance: 5-hydroxy-5-(4'chlorophenyl)-2, 3-dihydro-5Himidazo-(2,1-a) isonidole (mazindol). Archives Internationales de Pharmacodynamie 1975;214:285-307.","journal-title":"Archives Internationales de Pharmacodynamie"},{"issue":"7","key":"ref_13","first-page":"227","article-title":"Suppression of renal excretion of fencamfamin in man","volume":"1969","author":"Vree, T.B.; Van Rossum, J.M.","unstructured":"Vree TB, Van Rossum JM. Suppression of renal excretion of fencamfamin in man. EurJ7 Pharmacol 1969;7:227-30.","journal-title":"EurJ7 Pharmacol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00003495-197611050-00002","article-title":"Anorectic drugs","volume":"11","author":"Craddock, D.","year":"1976","unstructured":"Craddock D. Anorectic drugs. Drugs 1976;11:378-93.","journal-title":"Drugs"},{"key":"ref_15","first-page":"1","article-title":"The sleep-waking cycle. Ergebnisse der Physiologie, biologischen Chemie und experimentellen","volume":"64","author":"Moruzzi, G.","year":"1972","unstructured":"Moruzzi G. The sleep-waking cycle. Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie 1972;64:1-165.","journal-title":"Pharmakologie"},{"key":"ref_16","first-page":"152","article-title":"British national formulary. No 7","author":"Committee, Joint Formulary","year":"1984","unstructured":"Joint Formulary Committee. British national formulary. No 7. London: British Medical Association, Pharmaceutical Society of Great Britain, 1984:152."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM197308232890806","article-title":"Treating problem children with stimulant drugs","volume":"289","author":"Sroufe, L.A.; Stewart, M.A.","year":"1973","unstructured":"Sroufe LA, Stewart MA. Treating problem children with stimulant drugs. N EnglJ Med 1973;289:407-13. (Accepted 12 December 1984)","journal-title":"N EnglJ Med"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.290.6476.1167","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.290.6476.1167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:52:43Z","timestamp":1765551163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.290.6476.1167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,4,20]]},"references-count":17,"journal-issue":{"issue":"6476","published-online":{"date-parts":[[1985,4,20]]},"published-print":{"date-parts":[[1985,4,20]]}},"alternative-id":["10.1136\/bmj.290.6476.1167"],"URL":"https:\/\/doi.org\/10.1136\/bmj.290.6476.1167","relation":{},"ISSN":["0267-0623","1468-5833"],"issn-type":[{"value":"0267-0623","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,4,20]]}}}